KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of GoodwillAmortization of GoodwillAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationAmortization - GoodwillCost of RevenueDepreciation ExpenseEBIATGross ProfitLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Teladoc Health (TDOC) Shares Issued (2016 - 2025)

Teladoc Health's Shares Issued history spans 12 years, with the latest figure at $2.9 million for Q4 2025.

  • On a quarterly basis, Shares Issued rose 184.23% to $2.9 million in Q4 2025 year-over-year; TTM through Mar 2026 was $2.3 million, a 41.06% decrease, with the full-year FY2025 number at $3.0 million, down 36.82% from a year prior.
  • Shares Issued hit $2.9 million in Q4 2025 for Teladoc Health, up from -$1.3 million in the prior quarter.
  • Over the last five years, Shares Issued for TDOC hit a ceiling of $11.9 million in Q3 2021 and a floor of -$2.1 million in Q2 2023.
  • Historically, Shares Issued has averaged $2.1 million across 5 years, with a median of $1.2 million in 2024.
  • Biggest five-year swings in Shares Issued: crashed 247.24% in 2023 and later soared 1670.69% in 2024.
  • Tracing TDOC's Shares Issued over 5 years: stood at $2.8 million in 2021, then crashed by 69.73% to $855000.0 in 2022, then tumbled by 93.22% to $58000.0 in 2023, then soared by 1670.69% to $1.0 million in 2024, then soared by 184.23% to $2.9 million in 2025.
  • Business Quant data shows Shares Issued for TDOC at $2.9 million in Q4 2025, -$1.3 million in Q3 2025, and $695000.0 in Q2 2025.